医药政策法规
- (2022-11-22)
高危经典型霍奇金淋巴瘤(cHL)的一线治疗!FDA批准CD30靶向药物Adcetris(安喜力):治疗≥2岁的儿科患者!
(2022-11-22)- (2022-11-22)
- (2022-11-22)
- (2022-11-21)
- (2022-11-21)
- (2022-11-21)
- (2022-11-21)
- (2022-11-21)
- (2022-11-21)
- (2022-11-21)
- (2022-11-21)
- (2022-11-21)
- (2022-11-16)
- (2022-11-16)
- (2022-11-15)
- (2022-11-15)
- (2022-11-15)
- (2022-11-15)
- (2022-11-14)
- (2022-11-14)
- (2022-11-14)
- (2022-11-12)
- (2022-11-11)
- (2022-11-11)
- (2022-11-11)
- (2022-11-11)
- (2022-11-11)
- (2022-11-11)
- (2022-11-11)
- (2022-11-10)
- (2022-11-10)
- (2022-11-10)
- (2022-11-10)
- (2022-11-09)
- (2022-11-09)
- (2022-11-09)
- (2022-11-09)
- (2022-11-09)
- (2022-11-08)
- (2022-11-08)
- (2022-11-08)
- (2022-11-08)
- (2022-11-08)
- (2022-11-08)
- (2022-11-08)
- (2022-11-08)
- (2022-11-07)
- (2022-11-07)
- (2022-11-07)
- (2022-11-07)
- (2022-11-07)
- (2022-11-07)
- (2022-11-07)
- (2022-11-05)
- (2022-11-05)
- (2022-11-05)
- (2022-11-04)
- (2022-11-04)
- (2022-11-04)